Symbol="OCX"
AssetType="Common Stock"
Name="OncoCyte Corp"
Description="OncoCyte Corporation, a molecular diagnostics company, researches, develops, and markets proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company is headquartered in Irvine, California."
CIK="1642380"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="35568400"
EBITDA="-22905000"
PERatio="None"
PEGRatio="0"
BookValue="0.318"
DividendPerShare="0"
DividendYield="0"
EPS="-0.09"
RevenuePerShareTTM="0.007"
ProfitMargin="0"
OperatingMarginTTM="-31.29"
ReturnOnAssetsTTM="-0.149"
ReturnOnEquityTTM="-0.184"
RevenueTTM="875000"
GrossProfitTTM="188000"
DilutedEPSTTM="-0.09"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.218"
AnalystTargetPrice="0.35"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.13"
PriceToBookRatio="0.648"
EVToRevenue="2.608"
EVToEBITDA="-0.362"
Beta="1.588"
num_52WeekHigh="22"
num_52WeekLow="3.8"
num_50DayMovingAverage="0.224"
num_200DayMovingAverage="0.379"
SharesOutstanding="164821000"
DividendDate="None"
ExDividendDate="None"
symbol="OCX"
open="4.11"
high="4.64"
low="3.89"
price="4.12"
volume="111265.00"
latest_trading_day="2023-07-25"
previous_close="0.20"
change="3.92"
change_percent="1987.1327%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="89"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="11"
Volume_recent_avg="435948"
Change_recent_avg="0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-0.74"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_30"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="11"
Aroon_momentum_negative="89"
image_negative_thumbnail_id_1="1160"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0194.jpeg"
image_negative_thumbnail_id_2="1108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="594"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_positive_thumbnail_id_1="614"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0094.jpeg"
image_positive_thumbnail_id_2="642"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
